Accelerating Europe’s Progress in CNS Gene Therapy

Navigating Europe-Specific Challenges & European Regulators Requirements; Optimizing Preclinical Research in Neurological Models & Revolutionizing Gene Therapy Delivery to CNS Targets in the Clinic

As programs advance globally, the 3rd Annual Gene Therapy for Neurological Disorders Europe meeting is the industry’s definitive forum dedicated to showcasing the European landscape’s progress and specific regulatory challenges as they move from rare neurological disorders to targeting more common diseases including Parkinson’s, epilepsy and neurodevelopmental disorders.

Returning as its first in-person meeting, with brand new speakers and companies joining the conversation, attend alongside 100 fellow preclinical, translational, clinical and commercial gene therapy experts to overcome your translational challenges and improve the delivery of your gene therapy to its CNS target, and optimize your European strategy as you move from rare to common patient populations.

To know more visit: https://ter.li/l4b1t3